Published in J Clin Pathol on October 01, 1981
Lipids and HCV. Semin Immunopathol (2012) 1.19
Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: clinical and epidemiological features. Gut (1983) 1.13
Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate. Gut (1985) 0.81
Clinical, biochemical, serological, histological and ultrastructural features of liver disease in drug abusers. Gut (1984) 0.78
Histologic study of chronic active hepatitis C; comparison with chronic active hepatitis B. Korean J Intern Med (1992) 0.75
Chronic hepatitis: a review. J R Soc Med (1985) 0.75
Hepatitis C virus: a historical perspective. Dig Dis Sci (1996) 0.75
Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology (1977) 2.50
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Acute and chronic hepatitis revisited. Review by an international group. Lancet (1977) 2.13
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95
Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology (1978) 1.89
Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med (1977) 1.63
The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med (1979) 1.54
Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology (1979) 1.28
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
Hepatitis "C" antigen in non-A, non-B post-transfusion hepatitis. Lancet (1978) 1.21
Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Pathol Microbiol Scand (1969) 1.16
Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis. Lancet (1979) 1.14
Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. N Engl J Med (1975) 1.10
Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut (1980) 1.03
New human hepatitis virus. Lancet (1979) 1.03
Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies. Lancet (1974) 1.01
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
Increase in primary liver cancer in the UK, 1979-94. Lancet (1997) 6.15
A classification of chronic hepatitis. Lancet (1968) 6.07
Vaccine-induced escape mutant of hepatitis B virus. Lancet (1990) 5.31
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet (1989) 5.16
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A (1996) 4.02
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Gonorrhoea in homosexual men and media coverage of the acquired immune deficiency syndrome in London 1982-3. Br Med J (Clin Res Ed) (1984) 3.95
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut (2001) 3.45
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology (1998) 3.31
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol (1978) 3.06
A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Lancet (1977) 2.90
The epidemiology of testicular cancer in young adults. Am J Epidemiol (1980) 2.90
Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS (1997) 2.88
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med (1979) 2.84
Spread of acute type-B hepatitis in London. Lancet (1973) 2.82
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Lancet (1985) 2.72
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet (2000) 2.58
Hepatitis C virus: evidence for sexual transmission. BMJ (1991) 2.50
The induction of tolerance to a soluble protein antigen by oral administration. Immunology (1974) 2.50
Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ (1991) 2.49
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J (1973) 2.21
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology (1989) 2.15
Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet (1973) 2.15
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology (1994) 2.00
Prophylactic oral acyclovir in recurrent genital herpes. Lancet (1984) 1.99
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
The pathology of hepatitis C. Hepatology (1992) 1.92
Evidence for a cerebral effect of the hepatitis C virus. Lancet (2001) 1.90
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet (1975) 1.90
Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7. BMJ (1989) 1.89
Sex-related differences among 100 patients with alcoholic liver disease. Br Med J (1977) 1.89
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun (2003) 1.88
Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Q J Med (1989) 1.88
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Hepatitis-associated antigen in chronic liver disease. Lancet (1969) 1.82
Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med (1996) 1.82
The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles. J Med Virol (1982) 1.81
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Hepatitis C virus transmitted by human bite. Lancet (1990) 1.77
Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet (1997) 1.71
8-Hydroxymanzamine A, a beta-carboline alkaloid from a sponge, Pachypellina sp. J Nat Prod (1994) 1.70
Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet (1995) 1.67
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66